U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 14, 2000
SELECT THERAPEUTICS, INC.
------------------------------------------------------------
(Exact name of small business issuer as
specified in its charter)
Delaware 000-27353 98-0169105
State or other jurisdiction Commission (I.R.S. Employer
incorporation or organization File Number Identification No.)
50 Cummings Park, Woburn, MA 01801
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(781) 939-0995
124 Mt. Auburn St., Suite 200 North, Cambridge, MA 02138
(Former name, former address and former fiscal year,
if changed since last report)
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant
(a) On December 14, 2000, Select Therapeutics, Inc. (the "Registrant") dismissed
its independent accountant, KPMG LLP (the "Former Accountant"). The reports of
the Former Accountant on the Registrant's consolidated financial statements for
the past two fiscal years (June 30, 2000 and 1999) contained no adverse opinion
or disclaimer of opinion and were not modified as to uncertainty, audit scope or
accounting principle except that such reports of the Former Accountant stated
that "...[Registrant] has suffered recurring losses from operations that raise
substantial doubt about its ability to continue as a going concern." During the
Registrant's two most recent fiscal years and through later interim periods, the
Registrant had no disagreements with its Former Accountant on any matter of
accounting principles or practices, financial statement disclosure or auditing
scope or procedure which if not resolved to the satisfaction of the Former
Accountant would have caused it to make reference thereto in its reports on
Registrant's financial statements for such years. Registrant's decision to
change accountants was approved by the Registrant's Board of Directors.
In accordance with Item 304(a)(3) of Regulation S-B, the Registrant has
provided the Former Accountant with a copy of the foregoing disclosure, and the
Former Accountant's letter to the Securities and Exchange Commission agreeing
with the foregoing statements made by the Registrant regarding the Former
Accountant shall be filed as an amendment.
(b) After consideration of the qualifications of various accounting firms and
following appropriate interviews, Registrant engaged PricewaterhouseCoopers LLC
("PwC") to act as its independent certified public accountants effective
December 14, 2000. During the two most recent fiscal years and subsequent
interim periods, Registrant has not consulted PwC regarding the application of
accounting principles to a specified transaction, either completed or proposed,
or the type of audit opinion that might be rendered on its financial statements,
or any matter that was the subject of a disagreement or a reportable event.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Select Therapeutics, Inc.
Dated: December 15, 2000 By: /s/ Robert Bender
---------------------
Robert Bender
Chairman of the Board
